Alpha Tau Medical Ltd. (DRTS) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped DRTS stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: Alpha Tau Medical Ltd. is well-positioned in the biotechnology sector, with promising technology and recent regulatory advancements boosting its outlook. While financial performance raises some concerns, the company's strategic partnerships and expanding global presence support a bullish one-year outlook. Clinical success is critical for sustaining long-term growth, and economic uncertainties pose potential risks. With strong fundamentals and market optimism, Alpha Tau shows potential to exceed market average returns in the coming years. The saved 1-year distribution is P10 $10.2, P50 $14, and P90 $18.2.
Last analyzed · Model: gpt-4o
Alpha Tau Medical Ltd. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $10.2 | Pessimistic plausible scenario |
| P50 | $14 | Median scenario |
| P90 | $18.2 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
Alpha Tau Medical, with recent positive regulatory approvals and successful clinical trial results, is poised for growth. Despite EPS misses and short-seller attacks, the analyst consensus remains a BUY, indicating bullish sentiment. The recent uptick in stock price and market developments provide a strong foundation for an optimistic outlook, although caution is warranted given ongoing financial underperformance.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this DRTS analysis generated?
July 2, 2026.
Is this a guaranteed DRTS prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full DRTS stock analysis · DRTS sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.